Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$15K Sell
428
-7,122
-94% -$258K 0.73% 26
2016
Q4
$274K Sell
7,550
-24
-0.3% -$859 1.3% 16
2016
Q3
$286K Sell
7,574
-453
-6% -$16K 1.41% 16
2016
Q2
$263K Sell
8,027
-973
-11% -$30.5K 1.28% 17
2016
Q1
$291K Buy
9,000
+83
+0.9% +$2.55K 1.26% 16
2015
Q4
$307K Sell
8,917
-957
-10% -$32.3K 1.32% 13
2015
Q3
$298K Buy
9,874
+356
+4% +$10.3K 1.33% 12
2015
Q2
$289K Sell
9,518
-549
-5% -$17.7K 1.2% 17
2015
Q1
$315K Buy
10,067
+161
+2% +$5.43K 1.25% 9
2014
Q4
$359K Buy
9,906
+6
+0.1% +$209 1.42% 9
2014
Q3
$345K Sell
9,900
-563
-5% -$19.1K 1.43% 11
2014
Q2
$323K Sell
10,463
-35
-0.3% -$959 1.36% 13
2014
Q1
$271K Buy
10,498
+34
+0.3% +$849 1.2% 15
2013
Q4
$272K Buy
10,464
+970
+10% +$23.5K 1.24% 17
2013
Q3
$218K Buy
9,494
+1,584
+20% +$36.5K 1.09% 21
2013
Q2
$192K Buy
+7,910
New +$187K 0.88% 28

Other funds holding INTC

New York Life Trust's INTC Position: Q1 2017 in Review

New York Life Trust reduced its Intel (INTC) stake by 94% in Q1 2017, selling an estimated $258K and leaving 428 shares worth $15K. The position accounts for 0.73% of the portfolio, ranked #26.

New York Life Trust first reported a position in INTC in Q2 2013 and has held it in 16 quarters since. The position peaked at $359K in Q4 2014. 1,953 funds tracked by Wall St. Rank hold INTC as of Q1 2017.

  • New York Life Trust held 428 shares of Intel worth $15K as of Q1 2017.
  • New York Life Trust sold 7,122 Intel shares in Q1 2017, an estimated $258K.
  • Intel made up 0.73% of New York Life Trust's portfolio in Q1 2017, its #26 holding.
  • New York Life Trust first reported a position in Intel in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's Intel position peaked at $359K in Q4 2014.
  • 1,953 funds tracked by Wall St. Rank held Intel as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.